Nasal Desmopressin Versus Oral Bisoprolol for Controlling Bleeding During Endoscopic Sinus Surgery
Status:
Not yet recruiting
Trial end date:
2022-11-01
Target enrollment:
Participant gender:
Summary
Functional endoscopic sinus surgery (FESS) is well established for treatment of chronic
rhinosinusitis and nasal polyps. Masking of the surgical field can lead to severe
complication as tissue injury, increase post-operative adhesions and scarring and even severe
orbital and brain injury In the current study we will investigate the effect of nasal
desmopressin versus oral bisoprolol for controlling bleeding and improving surgical field
clarity during functional endoscopic sinus surgery